Reducing Treatment Burden in Lifestyle Medicine in Viet Nam: Patient Workload, Capacity, and Minimally Disruptive Care
EVIDENCE & CLINICAL PRACTICEHEALTH EQUITY & PLANETARY HEALTH
11/22/202628 min read


Reducing Treatment Burden in Lifestyle Medicine in Viet Nam: Patient Workload, Capacity, and Minimally Disruptive Care
Last reviewed: November 22, 2026
A patient leaves a healthcare appointment with several recommendations. They are encouraged to improve their diet, become more physically active, monitor their blood pressure, maintain a regular sleep schedule and return for follow-up. They may also need to continue prescribed medications, arrange laboratory tests and coordinate care with different healthcare professionals.
Each recommendation may have a sound clinical purpose. Some are essential for controlling disease or preventing complications, while others are intended to support healthier habits over time. Yet when these recommendations are considered together, an important question emerges: how much work does the healthcare plan require from the person expected to follow it?
A patient may understand every instruction and genuinely want to improve their health but still struggle to fit the combined demands into everyday life. Employment, family responsibilities, financial pressures, physical symptoms and unexpected events do not disappear when treatment begins.
Healthcare professionals routinely consider whether an intervention is clinically appropriate. They may be less accustomed to examining how much time, effort and coordination it requires outside the consultation room.
This is particularly relevant to Lifestyle Medicine, where much of the recommended care takes place in people's homes, workplaces and communities. Changes in nutrition, physical activity, sleep and other health behaviors involve repeated decisions and actions that must be sustained alongside ordinary responsibilities.
Even a scientifically sound recommendation may become difficult to maintain when the demands of carrying it out exceed the person's available resources.
The concept of treatment burden provides a way to understand this challenge. It concerns the work people undertake to manage their healthcare and the effects of that work on their functioning and well-being.
For Viet Nam, treatment burden deserves attention as healthcare services strengthen prevention, chronic disease management and continuity of care.
The objective is not to reduce necessary healthcare simply because a treatment plan is demanding. It is to provide appropriate care while avoiding unnecessary work and disruption that offer little additional benefit.
This principle lies at the heart of Minimally Disruptive Medicine.
Understanding Treatment Burden
Treatment burden is sometimes confused with disease severity, the number of medications prescribed or difficulty following medical advice. These factors may contribute to treatment burden, but they are not equivalent.
Disease burden concerns the effects of illness itself, including symptoms, complications and limitations in daily functioning. Treatment burden concerns the work required to manage illness and healthcare, together with the consequences of that work for everyday life.
This work may include taking medications, arranging appointments, traveling to healthcare facilities, monitoring symptoms, undergoing investigations, completing administrative procedures and following dietary or physical activity recommendations.
It may also involve learning unfamiliar medical information, coordinating instructions from different professionals, purchasing equipment and making repeated decisions about competing health priorities.
Some tasks are brief but frequent. Others occur less often but require considerable planning, expense or emotional effort.
For one patient, measuring blood pressure at home may be straightforward. Another may struggle to operate the device, understand the readings or determine when professional advice is needed. Some people may also experience anxiety when interpreting measurements, particularly when they are uncertain about what the results mean.
Dietary recommendations offer another example. Preparing meals according to a recommended eating pattern may be manageable in one household but demanding in another where family members share meals, food choices depend on limited income or working hours leave little time for preparation.
Two people with similar diagnoses may therefore experience very different levels of treatment burden.
The burden cannot be understood simply by counting medications, appointments or prescribed activities. What matters is how those requirements affect the individual and whether the person has sufficient resources to manage them.
Patient Workload and Capacity: Understanding the Balance
The Cumulative Complexity Model, developed by Shippee and colleagues in 2012, provides a useful foundation for understanding the relationship between healthcare demands and patients' ability to manage them.[1]
The model emphasizes the interaction between workload and capacity.
Patient workload includes the activities required to manage health conditions and treatment, together with responsibilities associated with everyday living.
Capacity refers to the resources people can draw upon to meet those demands. These may include physical functioning, emotional well-being, available time, financial resources, health literacy, practical skills, social support and access to healthcare services.
Capacity should not be confused with intelligence, motivation or personal resilience.
A patient may understand their condition and value the recommended treatment but have limited time because they work long hours or care for family members. Another person may have adequate financial resources but experience fatigue, pain or functional limitations that make certain activities difficult.
Capacity also changes over time.
A plan that is manageable during a period of stable health may become overwhelming after an acute illness, employment change or family emergency. Someone who previously attended appointments independently may suddenly need assistance with transportation or everyday activities.
The relationship between workload and capacity is therefore dynamic.
When healthcare demands consistently exceed available capacity, patients may struggle to complete important tasks. The consequences can extend beyond treatment adherence to affect employment, relationships, psychological well-being and quality of life.
These difficulties should not automatically be interpreted as a lack of commitment. They may indicate that the healthcare plan does not fit the person's circumstances.
A systematic review published by Smyth and colleagues in May 2025 examined the application of Burden of Treatment Theory across 30 publications.[2]
The review reinforced the importance of understanding the healthcare work undertaken by patients, the resources available to them and the organizational circumstances influencing their ability to manage treatment.
The authors identified the theory as a useful framework for understanding treatment burden across different settings while recognizing the need for further empirical research and contextual adaptation.
These models help explain why individually reasonable recommendations may become difficult to sustain when combined.
However, a conceptual framework does not itself establish that a particular intervention will reduce treatment burden or improve clinical outcomes. Those questions require separate evaluation.
What Is Minimally Disruptive Medicine?
The concept of Minimally Disruptive Medicine was articulated by May, Montori and Mair in a 2009 article published in The BMJ.[3]
The authors argued that chronic disease care should aim to achieve meaningful clinical benefits while minimizing the disruption created by treatment and healthcare activities.
The approach challenges an assumption that can emerge when several conditions are managed independently: that adding every recommended intervention will necessarily produce the best overall care.
A patient living with multiple chronic conditions may receive separate treatment plans from different healthcare professionals. Each plan may be appropriate when considered in isolation.
Together, however, the recommendations may require repeated appointments, complex medication schedules, monitoring, lifestyle changes and administrative work that exceed the person's available capacity.
Minimally Disruptive Medicine encourages healthcare professionals to examine the combined workload, understand what matters to the patient and organize care in ways that reduce avoidable disruption.
This does not mean minimizing medical attention or withholding effective treatment.
A person at substantial risk of complications may require intensive monitoring, multiple medications or frequent clinical review. These activities may remain necessary despite the burden they create.
The aim is to ensure that healthcare demands are proportionate to expected benefits and delivered in the most manageable way reasonably possible.
For Lifestyle Medicine, this may involve prioritizing a manageable number of behavior changes, coordinating recommendations across conditions and reducing unnecessary administrative or monitoring tasks.
Minimally Disruptive Medicine is best understood as a patient-centered approach to care design. It is not a separate licensed medical profession, a replacement for clinical guidelines or a standardized treatment proven to improve every patient outcome.
Why Lifestyle Medicine Needs to Consider Treatment Burden
Lifestyle Medicine often requires patients to perform much of the work outside healthcare facilities.
Healthcare professionals can explain nutritional recommendations, recommend appropriate physical activity and discuss healthier sleep routines. Patients must then translate that advice into decisions about shopping, meal preparation, commuting, employment, household responsibilities and personal time.
Some changes become easier as routines develop. Others continue to require planning and effort.
The workload may become substantial when several interventions are introduced simultaneously.
Consider a person receiving a detailed dietary plan, a scheduled exercise program, daily self-monitoring requirements and regular lifestyle coaching. Each component may have a reasonable purpose, but together they may compete with the person's employment, family life and existing medical treatment.
The problem becomes more pronounced when lifestyle programs are added to ongoing care rather than integrated with it.
A patient with hypertension may already attend medical follow-up appointments and monitor blood pressure. Introducing a separate Lifestyle Medicine program could add further visits, questionnaires and records that duplicate information collected elsewhere.
More activity does not necessarily mean more effective care.
The clinical team should consider whether proposed lifestyle interventions complement existing treatment, what additional work they require and whether some activities can be simplified or coordinated without reducing meaningful benefit.
A scientifically appropriate intervention may still need adjustment to make its delivery feasible.
This is not an argument against comprehensive Lifestyle Medicine. It is an argument for integrating evidence-based recommendations into care in a way patients can realistically maintain.
Treatment Burden Is Not the Same as Poor Adherence
Healthcare professionals sometimes encounter patients who miss appointments, provide incomplete monitoring records or struggle to follow recommended routines.
These situations are often described as adherence problems. However, adherence alone does not explain why someone cannot complete a task.
A patient may understand and agree with a recommendation but lack the equipment, money, time or practical assistance required. Another may receive conflicting instructions from different clinicians. Someone may miss follow-up because attending the appointment requires substantial travel, unpaid time away from work or childcare arrangements.
Repeatedly emphasizing adherence may offer little benefit when the main difficulty lies in how care is organized.
A treatment-burden perspective encourages clinicians to ask which parts of the plan are difficult and why.
The discussion may reveal a need for clearer instructions, better coordination, practical assistance or a revised clinical approach.
Not every difficulty can be resolved by simplifying treatment. Some activities remain important despite inconvenience, and patients may need additional support to complete them safely.
Importantly, a person can experience substantial treatment burden while remaining highly adherent.
Someone may take every medication, attend every appointment and complete every monitoring task at considerable personal cost. Adherence rates alone are therefore insufficient to determine whether a healthcare plan is manageable.
A patient-centered assessment should consider not only whether tasks are completed but also what completing them requires.
What Recent Research Tells Us About Treatment Burden
A scoping review published in the Journal of Patient-Reported Outcomes on September 26, 2026, examined patient-reported measures of treatment burden among people living with long-term conditions.[4]
Duncan and colleagues included 204 studies and identified 53 validated patient-reported outcome measures, together with 22 additional measures developed specifically for individual studies.
However, only 10 measures explicitly or comprehensively assessed treatment burden.
This distinction matters because many studies use instruments measuring treatment satisfaction, self-management or quality of life without capturing the full experience of healthcare workload.
Across the included research, treatment burden varied by population and condition.
Higher burden was associated with a greater number of long-term conditions, younger age, poorer mental health and lower social support. Greater treatment burden was also associated with lower quality of life.
These findings require careful interpretation.
The review does not establish that younger adults always experience more treatment burden than older adults. The observed relationships depend on the populations studied, the measures used and the analyses performed.
Likewise, an association between treatment burden and poorer quality of life does not establish that treatment burden independently causes every observed difference.
Nevertheless, the review reinforces the importance of treatment burden as a meaningful dimension of patient experience.
It also highlights a measurement challenge: healthcare organizations should not assume that every questionnaire described as a treatment-burden measure captures the same concept or has been validated for every population.
This is particularly relevant when considering the use of international instruments in Viet Nam.
Does Reducing Treatment Burden Improve Patient Outcomes?
The rationale for reducing unnecessary healthcare workload is compelling, but evidence demonstrating the effectiveness of specific treatment-burden reduction interventions remains more limited.
The ICAN Discussion Aid provides a useful example.
ICAN was developed to help patients and healthcare professionals discuss the work involved in managing chronic conditions and the capacity available to perform that work.[5]
The tool was intended to make often overlooked aspects of everyday life visible during clinical encounters. Its development involved patient-centered design, observations of consultations and iterative testing.
However, a well-designed discussion tool does not automatically produce better outcomes.
A mixed-methods cluster-randomized trial published in PLOS ONE in December 2024 evaluated ICAN across eight primary care clinics in four US healthcare systems.[6]
The study involved 98 clinicians and 1,733 patients living with chronic conditions.
In the main mixed-effects analyses, the researchers found no statistically significant differences between ICAN and usual-care sites across the principal outcomes.
Some adjusted difference-in-differences analyses favored ICAN for patient self-efficacy in managing chronic disease, confidence in communicating with clinicians and healthcare professionals' assessment of chronic illness care.
However, implementation was limited.
Chart review found evidence of ICAN use in approximately 19% of eligible encounters at intervention sites.
Qualitative findings suggested that meaningful conversations could emerge when patients and clinicians used the tool as intended. Nevertheless, the trial did not demonstrate a clear and consistent improvement in treatment burden or most other evaluated outcomes.
An important limitation was the low and inconsistent uptake of the intervention. The findings therefore do not establish that a well-implemented version of ICAN would necessarily be ineffective, but neither do they demonstrate that introducing the tool will reliably improve outcomes.
For Vietnamese healthcare organizations, the lesson is that new discussion aids require appropriate training, workflow integration and evaluation.
A tool may be conceptually useful without producing measurable benefits when its implementation is inconsistent.
Measuring Treatment Burden Without Adding More Work
Patient-reported measures can help clinicians understand difficulties that are not apparent from laboratory results or medical records.
Established instruments include the Treatment Burden Questionnaire (TBQ), the Patient Experience with Treatment and Self-Management (PETS) and the Multimorbidity Treatment Burden Questionnaire (MTBQ).[7–9]
These instruments differ in content, length, target populations and measurement properties.
The TBQ was developed to assess the workload associated with healthcare and its impact on patients. PETS evaluates several aspects of treatment and self-management, including healthcare appointments, medication management and the consequences of healthcare work. The MTBQ was developed specifically for people living with multiple long-term conditions in primary care.
More recently, the Treatment Burden for Multimorbidity Scale (TBMS) was developed and evaluated in a study published in Nursing & Health Sciences in March 2026.[10]
The resulting 12-item instrument assesses two domains: healthcare tasks and their impacts.
Psychometric testing involved 503 participants at baseline and 313 participants at six-month follow-up.
The study reported favorable findings for reliability, construct validity and responsiveness in the population examined.
These findings are encouraging, but they do not establish that the instrument has been validated for routine use among Vietnamese patients.
Before adopting an international measure, a healthcare organization should consider its intended purpose, relevance to the target population, language, cultural suitability and measurement properties.
Translation alone is not sufficient to establish measurement equivalence. Appropriate cultural adaptation and psychometric evaluation may be necessary.
The burden of measurement itself also deserves attention.
A lengthy questionnaire administered repeatedly may create additional work for the very patients whose treatment burden the organization hopes to reduce.
In some settings, a brief clinical conversation may be more useful than a formal assessment instrument. Structured measurement may be appropriate when an organization needs comparable information for research, service evaluation or systematic improvement.
The choice should depend on the intended purpose.
The objective is to obtain information that can guide meaningful action, not to introduce another administrative requirement.
Making the Patient's Work Visible
Healthcare professionals may not see much of the work their recommendations create.
A prescription or referral appears in the medical record, but the effort required to act on it may remain invisible.
A patient may need to arrange transportation, request time away from work, purchase supplies, reorganize family responsibilities or ask someone to accompany them to an appointment.
A dietary recommendation may involve shopping at different locations, preparing separate meals or negotiating changes in household food preferences.
A home-monitoring plan may require purchasing equipment, learning how to use it, recording results and deciding when to contact a healthcare professional.
Some of these activities may depend on family members or informal caregivers.
Understanding the workload requires asking about it.
A clinician may explore what the patient currently does to manage their health, which activities take the most time and which have become difficult. The conversation may also reveal whether certain tasks create anxiety, frustration or conflict with other responsibilities.
The most medically visible activity is not necessarily the most burdensome.
One patient may find taking several medications manageable but struggle with transportation to appointments. Another may have convenient access to healthcare but find dietary instructions difficult to reconcile with family responsibilities.
The purpose is to identify opportunities to improve care without assuming that every difficulty reflects unwillingness to follow recommendations.
The conversation should be collaborative, allowing patients to describe the circumstances affecting their ability to carry out the plan.
Reducing Workload Without Compromising Necessary Care
Once treatment burden has been identified, the healthcare team can consider whether some demands can be reduced safely.
An obvious starting point is unnecessary duplication.
Patients receiving care from several departments may be asked to repeat similar histories, complete the same questionnaires or provide information already available in their medical records.
Better coordination may reduce this work while preserving necessary clinical information.
Appointment arrangements may also be reviewed.
Where clinically appropriate and operationally feasible, coordinating compatible follow-up activities can reduce travel, waiting time and repeated absences from work.
However, combining appointments should not delay necessary assessment or create visits so long that they become difficult to tolerate.
Self-monitoring is another area requiring individualized decisions.
Not every patient needs the same frequency or type of home measurement. Monitoring should reflect the clinical purpose, the person's condition, treatment risks and applicable professional guidance.
Reducing unnecessary logging may improve feasibility, but clinically indicated safety monitoring must continue.
Lifestyle recommendations can also be prioritized.
A patient does not necessarily need to begin several intensive behavior-change activities simultaneously. The healthcare team may identify a manageable number of priorities that offer meaningful benefit and reflect the patient's preferences.
For example, someone struggling with several changes may benefit from first establishing one realistic dietary or physical activity goal before introducing additional tasks.
Such prioritization should not mean abandoning necessary treatment.
In some circumstances, reducing burden requires providing more support rather than fewer services.
A patient may need assistance learning to use a monitoring device, clearer instructions or better coordination with another healthcare professional.
The most appropriate response is the one that improves the fit between care requirements and available capacity while maintaining clinical effectiveness and safety.
Digital Health Can Reduce Burden or Create New Demands
Digital health technologies are often presented as ways to make healthcare more convenient.
Remote consultations may reduce travel. Electronic records may improve communication. Mobile applications can organize information, provide reminders and support self-management.
These features can be valuable, particularly for people who have difficulty attending frequent appointments.
However, digital technology can also transfer work from healthcare organizations to patients.
A person may be expected to maintain several applications, enter information repeatedly, interpret automated messages or respond to frequent notifications.
What appears efficient from the provider's perspective may create additional demands for the person receiving care.
A systematic review published in the Journal of Medical Internet Research in November 2025 examined the effects of digital interventions on treatment burden among people living with chronic conditions.[11]
The review included 46 studies involving telehealth, informational resources, self-management tools and other digitally facilitated services.
Many studies reported ways in which digital interventions could support patients, including improved access to information, more convenient communication and assistance with self-management.
However, the review also identified potential problems involving accessibility, time-consuming tools, technical difficulties, fear and anxiety.
The evidence was heterogeneous, with many studies using qualitative or mixed-methods designs.
The findings therefore do not establish that every digital intervention reduces treatment burden or that digital care is universally preferable to in-person services.
For Vietnamese healthcare organizations, the relevant question is not simply whether a digital tool can replace an existing process.
It is whether the tool reduces the overall work required from patients while preserving appropriate access, clinical safety and continuity of care.
An application that simplifies one administrative activity but requires extensive daily data entry may not represent a net improvement.
Patients should also have appropriate alternatives when digital participation is not feasible.
Technology should support healthcare rather than make it increasingly difficult for people with limited digital skills, connectivity or resources.
Treatment Burden, Equity, and Family Responsibilities
The same healthcare plan may create very different demands depending on a person's circumstances.
Someone with flexible working hours may attend appointments without substantial difficulty. Another person may lose income each time they visit a healthcare facility.
A patient living close to a hospital may find regular follow-up convenient, while someone living farther away may face substantial travel time and transportation costs.
A recommendation to prepare fresh meals may be manageable for someone with suitable facilities, adequate income and household support. It may be difficult for a person who works irregular hours, has limited food access or carries significant caregiving responsibilities.
These differences do not necessarily reflect unequal motivation. They reflect differences in the resources available to perform healthcare work.
Treatment burden may therefore contribute to inequity when healthcare services assume that every patient has similar capacity.
Programs may unintentionally favor people with greater financial resources, more flexible schedules, better digital access and stronger practical support.
Those facing the greatest barriers may be more likely to miss appointments or discontinue participation.
If outcomes are assessed only among people who remain engaged, the findings may not adequately reflect the experiences of those who found the intervention most burdensome.
Treatment burden also extends beyond the patient.
Family members may help arrange transportation, organize medications, prepare meals, monitor symptoms and communicate with healthcare professionals.
Their support can make treatment more manageable, but it can also create additional work for the household.
A care plan that appears feasible during a consultation may depend heavily on unpaid activities performed by a spouse, adult child or another caregiver.
Healthcare professionals should not assume that this support is unlimited or always available. Nor should they assume that patients want family members involved in every aspect of care.
When appropriate and with the patient's agreement, discussions may explore which activities require assistance and whether the existing arrangements are sustainable.
The caregiver's circumstances may also matter.
A plan that depends on daily transportation or the preparation of several separate meals may become difficult when the caregiver's employment or health situation changes.
These considerations are particularly relevant to Lifestyle Medicine because many recommended activities take place within shared households.
An equity-informed approach should examine who can realistically participate in care and which requirements create avoidable barriers.
Reducing unnecessary workload can contribute to more equitable care, but it must not become a reason to offer less effective treatment to people with fewer resources.
The goal is to make appropriate care more feasible, not to lower clinical expectations because a patient faces disadvantage.
The Vietnamese Context: Access, Continuity, and Everyday Workload
Viet Nam continues to strengthen primary healthcare, prevention and long-term management of noncommunicable diseases.
These developments create opportunities to integrate evidence-based Lifestyle Medicine into routine care. They also make it important to understand the practical demands placed on patients.
A World Health Organization report published in December 2025, Primary Health Care in Viet Nam: A Review of the Commune Health System, examined the country's commune-level healthcare system and identified opportunities to strengthen service delivery, financing, governance and coordination.[12]
The report provides relevant context for understanding how healthcare organization influences people's experiences of accessing services.
Vietnamese research published in 2026 also illustrates barriers affecting continuity of care.
A sequential mixed-methods study published online in the Journal of Health Services Research & Policy in July 2026 examined the use of regular hypertension care in Viet Nam.[13]
The quantitative component analyzed a household survey of 1,706 adults with self-reported hypertension across six provinces. The qualitative component involved interviews with 13 patients living in two rural communes within Hanoi.
Among surveyed participants, 44.2% did not seek regular facility-based hypertension care.
The researchers also identified substantial variation in the type of healthcare facilities used for regular hypertension management.
The qualitative findings highlighted barriers including out-of-pocket costs, medicine stockouts, long waiting times, limited awareness and difficulties with provider communication.
These findings are relevant because they illustrate how service organization and financial circumstances may influence continuity of care.
However, the study did not directly measure treatment burden using a validated treatment-burden instrument.
The proportion of participants not receiving regular facility-based care should therefore not be presented as the prevalence of treatment burden in Viet Nam.
Nor does the study establish that a particular Minimally Disruptive Medicine intervention would improve hypertension outcomes.
What it demonstrates is that practical and organizational barriers can affect people's ability to obtain and continue care.
For Vietnamese healthcare organizations, reducing unnecessary patient workload may require improvements in appointment arrangements, communication, service coordination and continuity.
These are organizational responsibilities as well as individual clinical concerns.
Clinical Safety Must Remain the Priority
A central risk in discussing treatment burden is that simplification may be misunderstood as reducing necessary care.
Some monitoring activities are essential because they help detect complications, identify treatment-related adverse effects or guide clinical decisions.
A patient using insulin or certain other glucose-lowering medications may require appropriate glucose monitoring, particularly when dietary intake or physical activity changes substantially.
Reducing that monitoring without clinical assessment could create safety risks.
Similarly, patients receiving treatment for hypertension, chronic kidney disease or other conditions may require scheduled follow-up and laboratory monitoring.
Those requirements should not be dismissed simply because they create inconvenience.
A more appropriate response may be to improve how monitoring is organized, explain its purpose more clearly or coordinate it with other necessary activities.
Medication changes require similar caution.
A patient who experiences substantial improvement after lifestyle intervention may need treatment review. However, improvement in a single clinical measurement does not automatically mean that prescribed medication should be reduced or discontinued.
Some treatments provide important benefits beyond their effects on one biomarker.
Any medication adjustment must be based on the patient's condition, relevant evidence and appropriate clinical assessment by an authorized healthcare professional.
Minimally disruptive care is not a justification for self-directed medication changes or withholding effective treatment.
Its purpose is to reduce avoidable work while preserving meaningful benefits and necessary safeguards.
Shared Decisions Should Include the Work of Treatment
Shared decision-making commonly focuses on the expected benefits and harms of different treatments.
Treatment burden introduces another consideration: how much work each option requires and how that work fits into the patient's life.
Two clinically appropriate approaches may differ in the number of appointments, amount of self-monitoring, complexity of medication schedules or requirements for daily routines.
These differences can matter to patients.
Healthcare professionals should explain the relevant clinical consequences while creating opportunities to discuss the practical demands associated with each option.
The decision should not be based solely on convenience. An option requiring less effort may also offer less benefit or carry greater risk.
These trade-offs should be discussed transparently.
When evidence supports more than one reasonable approach, the patient's priorities may appropriately influence the choice.
When a particular intervention is clinically necessary, the discussion may focus on how to make it more feasible rather than whether to omit it.
International guidance provides useful examples.
The United Kingdom's National Institute for Health and Care Excellence guideline NG56, Multimorbidity: Clinical Assessment and Management, recommends considering treatment burden, patient goals and the organization of care.[14]
The guideline recognizes that appointments, medications and nonpharmacological treatments can contribute to burden.
It recommends discussing how treatment affects daily life, reviewing the overall plan and considering opportunities to coordinate care, reduce unnecessary appointments and develop individualized management arrangements.
These are useful principles for patient-centered care.
However, NICE guidance is not a legally binding Vietnamese clinical standard. Its application must be considered within the applicable local professional and regulatory framework.
A Practical Treatment-Burden Review in Vietnamese Outpatient Care
Consider a hypothetical outpatient clinic providing care for adults with hypertension and other cardiometabolic risk factors.
The clinic offers evidence-based medical treatment together with nutrition counseling, physical activity support and regular follow-up.
Healthcare professionals notice that some patients frequently miss lifestyle education appointments or provide incomplete home-monitoring records.
Rather than assuming that these patients lack motivation, the clinic decides to examine the workload associated with its care pathway.
Patients are invited to describe what they currently do to manage their health and which activities they find most difficult.
Some explain that they attend separate appointments for medical review, nutrition counseling and lifestyle education. Others report recording similar information in several forms or digital systems.
A few patients describe difficulties taking time away from work, while others find it challenging to interpret home-monitoring results.
The clinical team reviews these experiences alongside the requirements of safe and effective care.
Where appropriate, compatible appointments may be coordinated without delaying necessary assessment. Duplicated educational or administrative tasks may be reduced.
Monitoring instructions can be clarified, and patients may receive better guidance about which findings require contact with a healthcare professional.
Patients who need more intensive clinical review continue to receive it.
The clinic also considers which lifestyle goals should be prioritized and whether some activities can be integrated into existing care.
Any changes affecting treatment or necessary monitoring remain subject to appropriate professional assessment and authorization.
The revised pathway is then evaluated.
Relevant measures may include patient-reported burden, travel and appointment demands, continuity of care, clinically important outcomes and potential safety concerns.
A reduction in appointment numbers alone would not establish success.
The organization must also determine whether necessary clinical assessments were completed and whether care remained appropriate.
This example illustrates a possible quality improvement approach. It is not a validated Vietnamese treatment-burden reduction protocol or a project already implemented by VLMA.
Evaluating Whether Care Has Become Less Burdensome
A treatment-burden improvement initiative should begin with a clear objective.
The healthcare organization needs to identify which demands it intends to reduce and why those activities may be unnecessary, excessive or poorly coordinated.
Evaluation should then examine whether the changes have made care more manageable without compromising clinical quality.
Patient-reported treatment burden may be useful, but it should not be the only outcome when safety is involved.
An intervention could reduce reported burden while also reducing access to necessary care. Conversely, a service change might reduce travel time and administrative work without producing an immediate change in a questionnaire score.
Both findings require interpretation.
Relevant measures may include healthcare contacts, travel demands, time expenditure, administrative tasks and patients' experiences of managing treatment.
Clinical measures remain important when an intervention could affect disease control, treatment safety or other patient-relevant outcomes.
The organization should also examine whether burdens have simply shifted elsewhere.
Replacing an in-person appointment with remote monitoring may reduce travel but increase the work associated with technology.
A system change that saves clinician time may require patients to complete additional forms. An intervention that reduces patient workload may increase demands on family caregivers.
These trade-offs should be examined rather than assumed to represent improvement.
When claims about comparative effectiveness are made, appropriate study designs are necessary.
A before-and-after evaluation can provide useful operational information but may not establish causality.
Qualitative feedback can help explain why a change was useful or burdensome, while quantitative measures can assess the frequency and magnitude of those experiences.
A credible evaluation considers consequences for patients, caregivers, healthcare professionals and the organization.
Measurement itself must also remain proportionate.
Patients should not be expected to complete extensive questionnaires, daily records or additional appointments solely because an organization wishes to demonstrate improvement.
If information collected through an assessment does not inform a clinical or service-improvement decision, its routine collection may need reconsideration.
The effort required to improve healthcare should itself be considered when deciding whether an improvement initiative is worthwhile.
Professional and Organizational Responsibilities in Viet Nam
Efforts to reduce treatment burden must remain consistent with the Vietnamese legal framework governing healthcare activities.
The Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides the principal legal framework for medical examination and treatment.[15]
Articles 9–13 address important patient rights, including access to information about healthcare services, protection of privacy and participation in decisions concerning treatment.
Article 62 addresses professional responsibilities concerning medical examination, the selection of treatment methods and prescribing medications.
These provisions are relevant when healthcare organizations consider modifying care pathways.
A facility may seek to make services more convenient, but decisions affecting clinical assessment, treatment, medication or necessary monitoring must remain with appropriately authorized practitioners.
Government Decree No. 96/2023/NĐ-CP and Ministry of Health Circular No. 32/2023/TT-BYT, as amended, establish additional applicable requirements.
Circular No. 25/2026/TT-BYT, issued on June 30, 2026, amended selected provisions of Circular No. 32/2023/TT-BYT and other healthcare regulations.[16]
Its general effective date was August 15, 2026, while Articles 2 and 3 took effect on July 1, 2026.
The Vietnamese regulatory framework does not establish Minimally Disruptive Medicine as a separate licensed clinical profession or a universally authorized treatment category.
A patient-centered approach to service design should therefore be distinguished from the legal authority to provide regulated healthcare activities.
The Law on Disease Prevention No. 114/2025/QH15, effective July 1, 2026, provides additional context for prevention and management of disease risks.[17]
Government Decree No. 165/2026/NĐ-CP, dated May 15, 2026, provides implementing provisions within the scope of that law and took effect on July 1, 2026.[18]
These instruments contribute to the national framework for preventive healthcare.
However, they do not automatically establish a national treatment-burden assessment requirement, a standardized Minimally Disruptive Medicine program or a universal reimbursement mechanism for related activities.
Healthcare organizations must determine which services they are legally permitted to provide and which professional, institutional or regulatory requirements apply to their proposed activities.
Data Protection and Research Governance
Assessing treatment burden may involve collecting information about medical conditions, finances, employment, family responsibilities and psychological well-being.
Some of this information is sensitive. Patients should understand why it is collected, how it will be used and who may have access to it.
The Law on Personal Data Protection No. 91/2025/QH15 and Government Decree No. 356/2025/NĐ-CP both took effect on January 1, 2026.[19,20]
Government Decree No. 102/2025/NĐ-CP, effective July 1, 2025, also establishes requirements for health data management within its applicable scope.[21]
Healthcare organizations should identify the lawful basis and purpose of processing personal information, limit collection to what is necessary and implement appropriate confidentiality and security safeguards.
A patient's description of financial difficulties, employment constraints or family circumstances should not automatically be disclosed to parties without an appropriate legal basis or legitimate need for that information.
Where external technology providers or other partners participate, responsibilities concerning data access and processing should be established clearly.
Treatment-burden evaluation may also involve research.
If an organization conducts biomedical research involving human participants or other activities requiring ethical review, the relevant institutional and regulatory requirements must be considered.
Circular No. 43/2024/TT-BYT, effective February 1, 2025, regulates the establishment, organization and operation of ethics committees in biomedical research.[22]
The need for ethics review or other authorization depends on the actual nature and design of the activity.
Routine service evaluation, quality improvement and biomedical research should not automatically be treated as identical. However, describing a project as quality improvement does not remove obligations that otherwise apply to its activities.
Patient participation, appropriate consent, confidentiality and professional oversight remain essential.
Making Lifestyle Medicine More Manageable
A treatment-burden perspective changes the questions healthcare professionals ask.
Instead of focusing only on whether a patient has followed instructions, the clinician also considers whether the instructions can reasonably be followed.
Rather than adding interventions one by one, the healthcare team examines the combined workload.
Instead of assuming that every additional measurement improves care, it considers whether the information is useful enough to justify the work required.
And rather than attributing difficulties entirely to motivation, the team considers how service design, resources and competing responsibilities influence the patient's capacity.
This approach does not diminish the importance of evidence-based treatment. It can strengthen care by improving the fit between clinical recommendations and the circumstances in which those recommendations must be implemented.
The most appropriate plan may still be demanding.
Some patients require intensive treatment, close monitoring or frequent follow-up because the expected benefits justify the additional work.
Others may benefit from simplifying administrative tasks, improving coordination or reducing activities that contribute little meaningful value.
The underlying principle is proportionality.
Healthcare should require the work necessary to provide meaningful benefit while avoiding demands that can reasonably be reduced.
Helping Healthcare Fit Better Into People's Lives
The success of Lifestyle Medicine depends partly on what happens after a patient leaves the consultation room.
A recommendation may be supported by strong scientific evidence, but the person receiving it must still find a way to carry it out. That process involves time, effort, resources and repeated decisions.
Treatment burden brings these often overlooked demands into clinical discussion.
Recent research confirms that treatment burden is a measurable and meaningful dimension of healthcare experience. However, assessment instruments vary, and evidence concerning the effectiveness of specific burden-reduction interventions remains limited.
The 2024 ICAN trial illustrates that a well-designed discussion tool does not necessarily produce measurable improvements when implementation is inconsistent.
The 2025 systematic review of digital interventions demonstrates that technology may reduce certain healthcare demands while creating new ones.
Research on hypertension care in Viet Nam also highlights practical barriers affecting continuity, although it does not directly measure treatment burden or validate a particular minimally disruptive care intervention.
Together, these findings support greater attention to how healthcare workload affects patients' ability to participate in necessary care.
For healthcare organizations, this may involve better coordination, fewer unnecessary tasks, clearer communication and greater attention to patient experience alongside clinical outcomes.
For clinicians, it means recognizing that treatment plans exist within people's lives, not apart from them.
For patients, it creates an opportunity to discuss practical difficulties without having those difficulties automatically interpreted as unwillingness or failure.
For the Vietnam Lifestyle Medicine Alliance (VLMA), treatment burden is relevant to evidence-based Lifestyle Medicine because it connects clinical effectiveness with feasibility, patient autonomy, equity and healthcare quality.
The objective is not to establish a new national treatment standard or promote Minimally Disruptive Medicine as a universally proven intervention.
It is to encourage healthcare professionals to consider how their recommendations affect everyday life and whether necessary care can be delivered with less avoidable disruption.
Good healthcare should not require people to organize their entire lives around treatment when a safer and more manageable approach is available.
The goal is to help patients receive the care they need while preserving as much capacity as possible to live the lives that matter to them.
That is where reducing treatment burden becomes part of responsible, patient-centered Lifestyle Medicine in Viet Nam.
References and Further Reading
Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative Complexity: A Functional, Patient-Centered Model of Patient Complexity Can Improve Research and Practice. Journal of Clinical Epidemiology. 2012;65(10):1041–1051. doi:10.1016/j.jclinepi.2012.05.005.
Smyth RC, Smith G, Alexander E, May CR, Mair FS, Gallacher KI. A Systematic Review of the Use of Burden of Treatment Theory. Journal of Multimorbidity and Comorbidity. 2025;15:26335565251314828. doi:10.1177/26335565251314828.
May C, Montori VM, Mair FS. We Need Minimally Disruptive Medicine. BMJ. 2009;339:b2803. doi:10.1136/bmj.b2803.
Duncan L, Dixon D, Allan J, et al. Patient-Reported Outcome Measures (PROMs) of Treatment Burden in Long-Term Conditions: A Scoping Review. Journal of Patient-Reported Outcomes. Published September 26, 2026. doi:10.1186/s41687-026-01195-x.
Boehmer KR, Hargraves IG, Allen SV, et al. Meaningful Conversations in Living With and Treating Chronic Conditions: Development of the ICAN Discussion Aid. BMC Health Services Research. 2016;16:514. doi:10.1186/s12913-016-1742-6.
Boehmer KR, Thota A, Organick-Lee P, et al. Care for Patients Living With Chronic Conditions Using the ICAN Discussion Aid: A Mixed Methods Cluster-Randomized Trial. PLOS ONE. 2024;19(12):e0314605. doi:10.1371/journal.pone.0314605.
Tran VT, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and Description of Measurement Properties of an Instrument to Assess Treatment Burden Among Patients With Multiple Chronic Conditions. BMC Medicine. 2012;10:68. doi:10.1186/1741-7015-10-68.
Eton DT, Yost KJ, Lai JS, et al. Development and Validation of the Patient Experience With Treatment and Self-Management (PETS): A Patient-Reported Measure of Treatment Burden. Quality of Life Research. 2017;26(2):489–503. doi:10.1007/s11136-016-1397-0.
Duncan P, Murphy M, Man MS, Chaplin K, Gaunt D, Salisbury C. Development and Validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ). BMJ Open. 2018;8:e019413. doi:10.1136/bmjopen-2017-019413.
Lee KS, Lee J, Kim M, Shin R. The Treatment Burden for Multimorbidity Scale: A Development and Psychometric Validation Study. Nursing & Health Sciences. 2026;28(1):e70318. doi:10.1111/nhs.70318.
Polus M, Keikhosrokiani P, Korhonen O, Behutiye W, Isomursu M. Impact of Digital Interventions on the Treatment Burden of Patients With Chronic Conditions: Systematic Review. Journal of Medical Internet Research. 2025;27:e66874. doi:10.2196/66874.
World Health Organization Regional Office for the Western Pacific. Primary Health Care in Viet Nam: A Review of the Commune Health System. World Health Organization; December 1, 2025. ISBN: 978-92-9062-115-7.
Nguyen GH, Do MT, Tran OTM, Ho HT, Jayasuriya R. What Drives Patients to Utilise Regular Hypertension Care at Primary Health Care Facilities in Vietnam? A Sequential Mixed-Methods Study. Journal of Health Services Research & Policy. Published online July 26, 2026. doi:10.1177/13558196261471353.
National Institute for Health and Care Excellence. Multimorbidity: Clinical Assessment and Management. NICE Guideline NG56. Published September 21, 2016.
National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, January 9, 2023, as amended. Office of the National Assembly, Consolidated Document No. 26/VBHN-VPQH, February 26, 2026.
Government of Viet Nam. Decree No. 96/2023/NĐ-CP, December 30, 2023, Detailing Selected Provisions of the Law on Medical Examination and Treatment, as applicable. Ministry of Health. Circular No. 32/2023/TT-BYT, as amended, including by Circular No. 25/2026/TT-BYT, June 30, 2026.
National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15, December 10, 2025. Effective July 1, 2026.
Government of Viet Nam. Decree No. 165/2026/NĐ-CP, May 15, 2026, Detailing and Guiding the Implementation of Selected Provisions of the Law on Disease Prevention. Effective July 1, 2026.
National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15, June 26, 2025. Effective January 1, 2026.
Government of Viet Nam. Decree No. 356/2025/NĐ-CP, December 31, 2025, Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. Effective January 1, 2026.
Government of Viet Nam. Decree No. 102/2025/NĐ-CP, May 13, 2025, on Health Data Management. Effective July 1, 2025.
Ministry of Health of Viet Nam. Circular No. 43/2024/TT-BYT, December 12, 2024, Regulating the Establishment, Organization and Operation of Ethics Committees in Biomedical Research. Effective February 1, 2025.
Editorial, Clinical and Regulatory Note
This article is published by the Vietnam Lifestyle Medicine Alliance (VLMA) for professional education, scientific knowledge exchange and discussion of responsible approaches to reducing treatment burden within evidence-based Lifestyle Medicine in Viet Nam.
It reviews selected international research, patient-centered care concepts, measurement approaches and relevant Vietnamese regulatory considerations. It does not constitute a Vietnamese national clinical guideline, an approved treatment-burden reduction protocol, a professional licensing standard, a healthcare reimbursement determination or an authoritative legal opinion.
The concepts of patient workload, patient capacity, treatment burden and Minimally Disruptive Medicine are presented as approaches to understanding and improving healthcare delivery. They should not be interpreted as universally validated clinical interventions or proof that a particular model will produce equivalent benefits in Vietnamese healthcare.
The international assessment instruments and discussion aids described have different purposes and measurement properties. Their inclusion does not imply that they have been validated for Vietnamese populations or approved for every clinical use.
The hypothetical examples and proposed service improvement approaches are illustrative. They are not presented as services already implemented, validated or formally endorsed by VLMA.
Reducing treatment burden must not result in the omission, inappropriate delay or discontinuation of clinically indicated medical assessment, investigations, treatment, medication monitoring, rehabilitation or specialist referral.
Clinical decisions, including changes to medication and necessary monitoring, must remain with appropriately authorized healthcare professionals acting within their lawful scope and the activities permitted for their healthcare facilities.
Lifestyle Medicine should complement evidence-based medical treatment rather than replace it.
Healthcare organizations introducing treatment-burden assessment or related service changes must comply with applicable Vietnamese requirements concerning medical examination and treatment, patient rights, confidentiality, personal-data protection and institutional responsibilities.
Research involving human participants or other activities requiring ethics review must follow applicable institutional and regulatory processes.
International professional guidance, including NICE NG56, is presented as reference material and does not automatically establish legally binding clinical standards in Viet Nam.
VLMA does not independently authorize healthcare services, grant professional practice licenses, approve treatment protocols, certify treatment-burden assessment instruments for regulatory purposes or establish nationally binding requirements for Minimally Disruptive Medicine through this article.
The scientific and regulatory materials referenced were reviewed through November 22, 2026. Healthcare organizations considering implementation should verify current legal requirements, applicable professional guidance and the suitability of proposed activities for their patient populations and healthcare settings.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
